Poplar Therapeutics gets $50M Series A for immunology ambitions

FierceBiotechEthyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza

Endpoints NewsShattuck raises $75M; Servier inks neuro ASO pact with n-Lorem Foundation

Endpoints NewsBiotech pay analysis: 12 execs with $35M+ M&A golden parachutes

BioPharma DiveAstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine

FierceBiotechNovartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B

BioWorldShenzhen Chipscreen Biosciences synthesizes new HDAC inhibitors

BioWorldKunming Taita Biotech discovers new angiogenesis inhibitors

BioWorldJiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

BioWorldColumbia researchers use base editing to modify human embryo genome

LabiotechHow Daiichi Sankyo aims to become a top five oncology player by 2035

PharmaVoiceAmid a flurry of biotech deals, China looks to keep innovation at home

CellPrion-based protein self-assembly tunes mutagenesis to enable rapid adaptation